These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35947079)

  • 21. Improving Continuous Glucose Monitoring Uptake in Underserved Youth with Type 1 Diabetes: The IMPACT Study.
    Lin T; Manfredo JA; Illesca N; Abiola K; Hwang N; Salsberg S; Akhtar Y; Mathioudakis N; Brown EA; Wolf RM
    Diabetes Technol Ther; 2023 Jan; 25(1):13-19. PubMed ID: 36223197
    [No Abstract]   [Full Text] [Related]  

  • 22. Uninterrupted continuous glucose monitoring access is associated with a decrease in HbA1c in youth with type 1 diabetes and public insurance.
    Addala A; Maahs DM; Scheinker D; Chertow S; Leverenz B; Prahalad P
    Pediatr Diabetes; 2020 Nov; 21(7):1301-1309. PubMed ID: 32681582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of insulin pump therapy in children and adolescents with type 1 diabetes and its impact on metabolic control: comparison of results from three large, transatlantic paediatric registries.
    Sherr JL; Hermann JM; Campbell F; Foster NC; Hofer SE; Allgrove J; Maahs DM; Kapellen TM; Holman N; Tamborlane WV; Holl RW; Beck RW; Warner JT;
    Diabetologia; 2016 Jan; 59(1):87-91. PubMed ID: 26546085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous glucose monitoring in children, adolescents, and adults with type 1 diabetes mellitus: analysis from the prospective DPV diabetes documentation and quality management system from Germany and Austria.
    Ludwig-Seibold CU; Holder M; Rami B; Raile K; Heidtmann B; Holl RW; ; ;
    Pediatr Diabetes; 2012 Feb; 13(1):12-4. PubMed ID: 22128781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Glycemia Risk Index Predicts Performance of Diabetes Self-Management Habits in Youth With Type 1 Diabetes Mellitus.
    Panfil K; Vandervelden CA; Lockee B; Tallon EM; Williams DD; Lee JM
    J Diabetes Sci Technol; 2024 Jul; 18(4):779-786. PubMed ID: 38708581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based Study.
    Johnson SR; Holmes-Walker DJ; Chee M; Earnest A; Jones TW; ; Craig M; Anderson K; Ambler G; Barrett H; Batch J; Bergman P; Cameron F; Colman P; Conwell L; Cooper C; Couper J; Davis E; de Bock M; Donaghue K; Fairchild J; Fegan G; Fourlanos S; Glastras S; Gray L; Hamblin S; Hofman P; Holmes-Walker DJ; Howard N; Jack M; James S; Jefferies C; Johnson S; Kao J; King BR; Lafferty A; Martin M; McCrossin R; Pascoe M; Paul R; Pawlak D; Peña A; Price S; Price D; Rodda C; Simmons D; Sinnott R; Sive A; Smart C; Stone M; Stranks S; Tham E; Verge C; Ward G; Wheeler B; Williams J; Woodhead H; Woolfield N; Zimmermann A
    Diabetes Care; 2022 Feb; 45(2):391-397. PubMed ID: 34872983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation Between the Glycemia Risk Index and Longitudinal Hemoglobin A1c in Children and Young Adults With Type 1 Diabetes.
    Panfil K; Redel JM; Vandervelden CA; Lockee B; Kahkoska AR; Tallon EM; Williams DD; Clements MA
    J Diabetes Sci Technol; 2024 Jul; 18(4):771-778. PubMed ID: 38715286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
    Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
    JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with Type 1 Diabetes.
    McGill DE; Volkening LK; Butler DA; Harrington KR; Katz ML; Laffel LM
    Diabetes Technol Ther; 2018 Jun; 20(6):434-439. PubMed ID: 29727245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
    Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
    JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial.
    Chase HP; Beck RW; Xing D; Tamborlane WV; Coffey J; Fox LA; Ives B; Keady J; Kollman C; Laffel L; Ruedy KJ
    Diabetes Technol Ther; 2010 Jul; 12(7):507-15. PubMed ID: 20597824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: Population data from the ČENDA registry.
    Šumník Z; Pavlíková M; Pomahačová R; Venháčová P; Petruželková L; Škvor J; Neumann D; Vosáhlo J; Konečná P; Čížek J; Strnadel J; Průhová Š; Cinek O;
    Pediatr Diabetes; 2021 May; 22(3):439-447. PubMed ID: 33533545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin Pump Use in Young Children with Type 1 Diabetes: Sociodemographic Factors and Parent-Reported Barriers.
    Commissariat PV; Boyle CT; Miller KM; Mantravadi MG; DeSalvo DJ; Tamborlane WV; Van Name MA; Anderson BJ; DiMeglio LA; Laffel LM
    Diabetes Technol Ther; 2017 Jun; 19(6):363-369. PubMed ID: 28581817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes.
    Sibiak R; Gutaj P; Mrzewka-Rogacz B; Mantaj U; Wender-Ozegowska E
    Diabetes Technol Ther; 2022 Jan; 24(1):42-53. PubMed ID: 34524000
    [No Abstract]   [Full Text] [Related]  

  • 38. A Decade of Disparities in Diabetes Technology Use and HbA
    Addala A; Auzanneau M; Miller K; Maier W; Foster N; Kapellen T; Walker A; Rosenbauer J; Maahs DM; Holl RW
    Diabetes Care; 2021 Jan; 44(1):133-140. PubMed ID: 32938745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement in Psychosocial Outcomes in Children with Type 1 Diabetes and Their Parents Following Subsidy for Continuous Glucose Monitoring.
    Burckhardt MA; Abraham MB; Mountain J; Coenen D; Paniora J; Clapin H; Jones TW; Davis EA
    Diabetes Technol Ther; 2019 Oct; 21(10):575-580. PubMed ID: 31335192
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
    Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.